A group including Cyclerion Therapeutics, Inc.'s Chief Executive Officer offered to acquire Certain Assets of Cyclerion Therapeutics, Inc. (NasdaqGS:CYCN) . on November 20, 2022.

A group including Cyclerion Therapeutics, Inc.'s Chief Executive Officer cancelled the acquisition of Certain Assets of Cyclerion Therapeutics, Inc. (NasdaqGS:CYCN) on November 22, 2022. After consultation with its legal and financial advisors, the Independent Board of Cyclerion Therapeutics has unanimously concluded that the proposal is not in the best interest of the Company.